logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Ying Huang

south china agricultural university
H指数:32
被引数:2,947

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Retinal OCTA parameters and the risk of worsening kidney function in patients with type 2 diabetes: a longitudinal cohort study

视网膜OCTA参数与2型糖尿病患者的肾功能恶化风险：一项纵向队列研究

Frontiers in Endocrinology
IF4.6
2026-09-150
OA
YH Ying Huang †; GC Gong Chen †; QF Qianhua Fang †; ZZ Zhiyun Zhao †; JS Juan Shi; YP Ying Peng; XW Xuetong Wang; CL Cong Liu; XW Xing Wei; LS Lin Sun; ZH Zhuomeng Hu; YX Yuening Xu; PX Ping Xue; JH Jie Hong; WG Weiqiong Gu; NL Na Li; YZ Yifei Zhang; XS Xi Shen; WW Weiqing Wang
Efficacy of metastatic lesion radiotherapy in de novo metastatic nasopharyngeal carcinoma patients receiving local regional radiotherapy and chemo-immunotherapy: a multicenter retrospective study

转移性病变放疗对接受局部区域放疗和化疗免疫治疗的原发性转移性鼻咽癌患者的疗效：一项多中心回顾性研究

Radiotherapy and Oncology
IF5.3
2025-09-230
PRE
Shui-Qing He; Shu-Hui Lv; Si-Qing Wen; null Lin-Wang; Ya-Hui Yu; Guo-Yi Zhang; Ding-Sheng Peng; Wei-Xin Bei; Chun-Lan Chen; Ze-Yu Zhao; Ying Huang; Yan-Qun Xiang; Guo-Ying Liu
The efficacy of immunotherapy combined with capecitabine versus immunotherapy alone as maintenance therapy in patients with de novo metastatic nasopharyngeal carcinoma: a retrospective propensity score matching study

免疫疗法联合卡培他滨与免疫疗法单药作为维持治疗在原发转移性鼻咽癌患者中的疗效比较：一项回顾性倾向性评分匹配研究

ESMO Open
IF8.3
2025-06-010
OA
S.-Q. He; S.-H. Lv; S.-Q. Wen; L. Wang; Z.-Y. Zhao; W.-X. Bei; Y. Huang; Y.-Q. Xiang; G.-Y. Liu
Single-cell transcriptome analysis reveals evolving tumour microenvironment induced by immunochemotherapy in nasopharyngeal carcinoma

单细胞转录组分析揭示了鼻咽癌中免疫化学疗法诱导的不断变化的肿瘤微环境

CLINICAL AND TRANSLATIONAL MEDICINE
IF6.8
2024-10-160
OAAI
Jiang, Yaofei; Bei, Weixin; Li, Wangzhong; Huang, Ying; He, Shuiqing; Zhu, Xiaobin; Zheng, Lisheng; Xia, Weixiong; Dong, Shuhui; Liu, Qin; Zhang, Chuanrun; Lv, Shuhui; Xie, Changqing; Xiang, Yanqun; Liu, Guoying
Surufatinib plus toripalimab combined with pemetrexed (A), and platinum (P) in patients (pts) with advanced non-squamous non-small cell lung cancer (nsq-NSCLC): Updated results of a single-center, phase II trial

苏鲁法替尼 plus 托瑞帕利姆单抗 combined with 帕emetrexed (A), and platinum (P) in patients (pts) with advanced non-squamous non-small cell lung cancer (nsq-NSCLC): Updated results of a single-center, phase II trial

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Fang, W. F.; Yang, Y.; Huang, Y.; Zhao, Y.; Zhang, Y.; Zhou, T.; Chen, G.; Zhao, S.; Ma, Y.; Hong, S.; Zhao, H.; Zhang, L.

研究方向

暂未获取到该数据
韩飞 封面图
韩飞
H 指数:58论文数:428被引数:1.1万
S
Shuiqing He
H 指数:4论文数:29被引数:49
Y
Yan‐Qun Xiang
H 指数:37论文数:189被引数:4,773
W
Wei-Xin Bei
H 指数:8论文数:30被引数:222
Y
Yingzhong Lin
H 指数:27论文数:94被引数:1,717
T
Tai-Xiang Lu
H 指数:28论文数:62被引数:2,733
W
Weiwei Xiao
H 指数:39论文数:328被引数:6,402
G
Guoyi Zhang
H 指数:28论文数:288被引数:3,212
S
Shu‐Hui Lv
H 指数:12论文数:47被引数:562
M
Menglong Wang
H 指数:40论文数:237被引数:4,756